MAVERICK Trademark

Trademark Overview


On Monday, April 11, 2016, a trademark application was filed for MAVERICK with the United States Patent and Trademark Office. The USPTO has given the MAVERICK trademark a serial number of 86971654. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 15, 2024. This trademark is owned by Harpoon Therapeutics, Inc.. The MAVERICK trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnosis and treatment of cancer; providing information in the field of cancer diagnosis and treatment; providing healthcare and medical information

Medical and pharmaceutical research services in the field of cancer; medical and pharmaceutical research services; pharmaceutical research and development in the field of cancer; pharmaceutical research and development; research, development, and testing services in the fields of pharmaceutical and biotechnology products; drug discovery, research, and development in the pharmaceutical and biotechnology fields

General Information


Serial Number86971654
Word MarkMAVERICK
Filing DateMonday, April 11, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 15, 2024
Registration Number5459564
Registration DateTuesday, May 1, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2016

Trademark Statements


Goods and ServicesMedical diagnosis and treatment of cancer; providing information in the field of cancer diagnosis and treatment; providing healthcare and medical information
Goods and ServicesMedical and pharmaceutical research services in the field of cancer; medical and pharmaceutical research services; pharmaceutical research and development in the field of cancer; pharmaceutical research and development; research, development, and testing services in the fields of pharmaceutical and biotechnology products; drug discovery, research, and development in the pharmaceutical and biotechnology fields

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 15, 2024
Primary Code042
First Use Anywhere DateFriday, January 6, 2017
First Use In Commerce DateFriday, January 6, 2017

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 15, 2024
Primary Code044
First Use Anywhere DateFriday, January 6, 2017
First Use In Commerce DateFriday, January 6, 2017

Trademark Owner History


Party NameTAKEDA PHARMACEUTICALS U.S.A., INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421

Party NameMAVERICK THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBRISBANE, CA 94005

Party NameMAVERICK THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBRISBANE, CA 94005

Party NameHarpoon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Party NameHarpoon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events


Event DateEvent Description
Thursday, April 14, 2016NEW APPLICATION ENTERED
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 16, 2016ASSIGNED TO EXAMINER
Tuesday, May 17, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 17, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, May 17, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 17, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, May 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 31, 2016ASSIGNED TO LIE
Monday, June 6, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 22, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 25, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 1, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2017SOU EXTENSION 1 FILED
Wednesday, March 1, 2017SOU EXTENSION 1 GRANTED
Friday, March 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 2, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 25, 2017SOU TEAS EXTENSION RECEIVED
Friday, August 25, 2017SOU EXTENSION 2 FILED
Friday, August 25, 2017SOU EXTENSION 2 GRANTED
Tuesday, August 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 23, 2018TEAS STATEMENT OF USE RECEIVED
Friday, February 23, 2018SOU TEAS EXTENSION RECEIVED
Friday, February 23, 2018SOU EXTENSION 3 FILED
Friday, February 23, 2018USE AMENDMENT FILED
Monday, February 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 1, 2018SOU EXTENSION 3 GRANTED
Thursday, March 1, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, March 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 25, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 27, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 1, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, January 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 1, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 15, 2024CANCELLED SEC. 8 (6-YR)